Eris Lifesciences has informed that the Board of Directors of the Company at their meeting held today August 04, 2020, duly approved / took on record the Unaudited Standalone Financial Results and the Unaudited Consolidated Financial Results for the quarter ended June 30, 2020, Declaration of Interim Dividend of Rs 5.50 (at the rate of 550%) on each fully paid-up equity share of Re 1 for the Financial Year 2020-21, and Fixed 14th August, 2020 as the record date to determine the names of the equity shareholders, who shall be entitled to receive the payment towards interim dividend for the financial year 2020-21. The payment of the interim dividend would be made to the eligible shareholders on or before 3rd September, 2020. The meeting of the Board of Directors commenced at 11:00 am and concluded at 01:05 pm.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1801.25 |
Dr. Reddys Lab | 1322.30 |
Cipla | 1489.70 |
Lupin | 2116.45 |
Zydus Lifesciences | 984.20 |
View more.. |